Clinically meaningful responses with dupilumab in adolescents with uncontrolled moderate-to-severe atopic dermatitis: post hoc analyses from a randomized clinical trial

Amy S. Paller, Ashish Bansal, Eric L. Simpson, Mark Boguniewicz, Andrew Blauvelt, Elaine C. Siegfried, Emma Guttman-Yassky, Thomas Hultsch, Zhen Chen, Paola Mina-Osorio, Yufang Lu, Ana B. Rossi, Xinyi He, Mohamed Kamal, Neil M. H. Graham, Gianluca Pirozzi, Marcella Ruddy, Laurent Eckert & Abhijit Gadkari
This Figshare page contains a video abstract and summary slide.
Disclosures Funding Open access was funded by Sanofi and Regeneron Pharmaceuticals, Inc. The current research was sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT03054428. The study sponsors participated in the study design; collection, analysis, and interpretation of the data; writing of the report; and the decision to submit the article for publication. Medical writing/editorial assistance was provided by Carolyn Ellenberger, PhD, of Excerpta Medica,...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.